Mago

Mago bark contains mangiferin, gallic acid, tannins, and polyphenolic compounds that exert antimicrobial and anti-inflammatory activity through free radical scavenging and inhibition of microbial cell wall synthesis. Preclinical studies on Mangifera indica bark extracts demonstrate significant antibacterial activity against oral pathogens, supporting its traditional Samoan use as a bark infusion for pediatric mouth infections, though no controlled human trials have validated this specific application.

Origin & History

Mangifera indica is native to South and Southeast Asia, with primary centers of diversity in India, Myanmar, and Bangladesh, where it has been cultivated for over 4,000 years. The tree thrives in tropical and subtropical climates with well-drained soils, full sun, and seasonal dry periods that trigger flowering. In the Pacific Islands, including Samoa where it is called 'mago,' the tree was introduced through Polynesian and later colonial trade networks and has naturalized widely across low-elevation coastal and inland areas.

Historical & Cultural Context

Mangifera indica has been integral to Ayurvedic and Unani medicine in South Asia for over two millennia, where bark decoctions were prescribed for hemorrhage, diarrhea, and oral ailments, and leaves were burned as fumigants for respiratory conditions. In Samoan traditional healing, the tree is known as 'mago,' and its bark infusion represents a specific pediatric application for mouth infections, reflecting a broader Pacific Islands ethnomedical tradition that applies astringent plant barks to mucosal surfaces. The tree's introduction to Polynesia through pre-colonial and colonial trade routes facilitated its integration into local healing systems, where knowledge of its use was transmitted orally across generations of traditional healers known in Samoa as 'fofo.' Across Southeast Asia and the Pacific, virtually every part of the mango tree—roots, bark, leaves, flowers, fruit peel, and kernel—carries documented ethnomedicinal roles, making it one of the most comprehensively utilized medicinal trees in tropical traditional pharmacopeias.

Health Benefits

- **Antimicrobial Activity**: Bark and leaf extracts of Mangifera indica contain tannins and gallic acid that disrupt bacterial membrane integrity and inhibit the growth of oral pathogens such as Streptococcus mutans, providing a phytochemical basis for its use in mouth infections.
- **Antioxidant Protection**: Mangiferin and total phenolics in mango leaves (79.47–183.29 mg/g GAE) scavenge free radicals with IC50 values as low as 16.81 μg/mL, reducing oxidative stress across tissues.
- **Anti-Inflammatory Effects**: Polyphenols including quercetin and mangiferin inhibit pro-inflammatory mediators, reducing swelling and pain associated with mucosal and systemic inflammation observed in preclinical models.
- **Antidiabetic Potential**: Mangiferin (found at 39.53–105.75 mg/g in leaf extracts) inhibits alpha-glucosidase activity and modulates insulin signaling pathways in animal studies, lowering postprandial blood glucose.
- **Gastroprotective Action**: Tannins and flavonoids in mango bark and fruit peel form a protective mucosal layer in the gastrointestinal tract, reducing ulceration and microbial colonization in ethnomedicinal contexts across tropical populations.
- **Hepatoprotective Effects**: Preclinical evidence indicates that mangiferin and gallic acid reduce hepatic oxidative stress markers and support liver enzyme normalization in chemically induced liver injury models.
- **Wound Healing and Tissue Repair**: Astringent tannins in the bark promote tissue contraction and reduce exudate in open wounds and mucosal lesions, consistent with traditional Pacific Island topical and infusion-based applications.

How It Works

Mangiferin, the dominant xanthone C-glucoside in Mangifera indica, acts as a potent antioxidant by donating hydrogen atoms to neutralize reactive oxygen species, and has been shown in cell-based studies to modulate NF-κB signaling pathways, thereby reducing transcription of pro-inflammatory cytokines such as TNF-α and IL-6. Gallic acid and hydrolyzable tannins present in the bark precipitate microbial surface proteins, disrupt bacterial phospholipid bilayers, and inhibit extracellular enzyme production, producing direct antimicrobial effects relevant to oral mucosal infections. Quercetin and kaempferol glycosides inhibit cyclooxygenase-2 (COX-2) enzymatic activity and modulate mitogen-activated protein kinase (MAPK) cascades, reducing arachidonic acid-derived inflammatory mediator synthesis. Collectively, these polyphenols also chelate metal ions required for microbial growth and free radical propagation, amplifying their combined antioxidant and antimicrobial efficacy across mucosal tissues.

Scientific Research

The evidence base for Mangifera indica consists predominantly of in vitro phytochemical characterization studies and animal model trials, with no published randomized controlled trials specifically evaluating bark infusion for pediatric oral infections in Samoan or other Pacific Island populations. Quantitative phytochemical analyses have consistently documented high phenolic content and antioxidant activity across leaf and bark fractions from multiple cultivars, with IC50 values for radical scavenging ranging from 16.81 to 67.67 μg/mL depending on variety and extraction method. Preclinical studies using rodent models have demonstrated antidiabetic, anti-inflammatory, and hepatoprotective outcomes, but these used standardized extracts at controlled doses not directly comparable to traditional bark infusion preparations. The overall clinical evidence is limited, and the Samoan ethnomedicinal application specifically lacks formal clinical validation, placing this use firmly in the category of traditional knowledge supported by preliminary phytochemical plausibility.

Clinical Summary

No clinical trials with defined sample sizes, randomization, or quantified effect sizes have been published for Mangifera indica bark infusion in the treatment of pediatric oral infections. Broader clinical investigation of mango-derived extracts has explored antidiabetic and antioxidant endpoints in small pilot studies, but these were not conducted in Pacific Island populations and used standardized leaf or fruit preparations rather than bark infusions. The absence of human data for the specific Samoan 'mago' application means that efficacy and safety inferences must be extrapolated from in vitro antimicrobial studies and phytochemical profiles rather than direct clinical outcomes. Confidence in therapeutic recommendations for this specific use remains low, and formal ethnopharmacological clinical trials are needed.

Nutritional Profile

Mango bark is not a dietary food source, but its medicinally relevant phytochemical profile includes tannins (approximately 0.977 mg/g in leaves as a reference), alkaloids (~0.300 mg/g), saponins (~0.244 mg/g), and significant polyphenols including mangiferin and gallic acid. Mango fruit, by contrast, provides α-tocopherol (1.33 mg/100 g fresh weight in Ataulfo cultivar), quercetin (1.7–19.3 mg/100 g), kaempferol 3-glucoside (6.7–77.3 mg/100 g), and proanthocyanidins including dimers (1.8 mg), trimers (1.4 mg), and oligomers (7.2 mg per 100 g). The peel and kernel concentrate the highest levels of mangiferin (4.2–169 mg/100 g) and gallic acid (up to 838 mg/100 g in some kernel extracts), as well as mangiferin gallate at 321 mg/100 g in certain extract fractions. Bioavailability of polyphenols from bark preparations is expected to be moderate given the hydrophilic nature of mangiferin and tannins, but is substantially influenced by matrix composition, preparation temperature, and gastrointestinal pH in pediatric patients.

Preparation & Dosage

- **Traditional Samoan Bark Infusion**: Bark sections are decocted in water and cooled to a safe temperature before topical oral application or rinse use in children; no standardized volume or concentration has been formally documented.
- **Leaf Aqueous Extract (Laboratory Reference)**: Water-ethanol solvent extractions yield an extraction index of 7.74–11.85% from dried leaf material; these parameters inform but do not define traditional preparations.
- **Ethanolic Leaf Extract (Preclinical Studies)**: Concentrations of 50–200 mg/kg body weight used in rodent antidiabetic and anti-inflammatory models; not directly translatable to human dosing without clinical trials.
- **Standardized Mangiferin Extract (Research Grade)**: Mangiferin content standardized to 39.53–105.75 mg/g in leaf extracts; no commercially standardized bark product for oral infection use is currently established.
- **Timing and Application**: Traditional oral rinse use suggests short-duration topical contact rather than systemic ingestion; frequency of application in Samoan practice is undocumented in peer-reviewed literature.
- **Precaution on Pediatric Dosing**: Given the absence of clinical pharmacokinetic data for bark preparations in children, dosing should not be extrapolated from adult or animal data without professional ethnomedicinal and medical oversight.

Synergy & Pairings

Mangifera indica bark preparations may exhibit enhanced antimicrobial efficacy when combined with other tannin-rich Pacific Island botanicals such as Psidium guajava (guava) bark, as their overlapping polyphenolic profiles produce additive disruption of bacterial membrane function against oral pathogens. Mangiferin's antioxidant activity is theoretically amplified in the presence of vitamin C (ascorbic acid), which regenerates oxidized phenolic radicals and extends their free radical scavenging capacity in aqueous mucosal environments. In traditional Pacific ethnomedicine, multi-plant preparations are common, and the co-administration of mango bark with coconut oil (Cocos nucifera) as an emollient vehicle may improve polyphenol contact time with oral mucosal surfaces while contributing additional medium-chain fatty acid antimicrobial activity.

Safety & Interactions

Mangifera indica bark infusion lacks formal clinical safety data, and no controlled adverse event reporting exists for its pediatric oral use in Samoa; qualitative phytochemical analyses of leaf extracts have confirmed the absence of cardiac glycosides, suggesting a relatively benign secondary metabolite profile at traditional use levels. Tannin-rich preparations may cause mucosal dryness or astringency at high concentrations, and prolonged ingestion of high-tannin extracts has been associated with reduced iron absorption and gastrointestinal irritation in general phytomedicine literature. Mango plant parts, particularly the sap, peel, and leaves, contain urushiol-like compounds related to anacardic acid that can cause contact dermatitis in sensitized individuals, and cross-reactivity with poison ivy (Toxicodendron spp.) has been documented clinically. No specific drug interaction data for mango bark preparations exists; theoretical interactions include potentiation of anticoagulant effects due to flavonoid content and potential modulation of CYP450 enzymes by mangiferin, warranting caution in patients on warfarin, antiplatelet agents, or hepatically metabolized medications.